Tag: Inflammation
No Increase in Adverse Events Seen With COVID-19 Vaccination After MIS-C
Minor adverse events seen in 48.6 percent of patients, most often arm soreness and/or fatigue
New Surveillance Case Definition Developed for MIS-C
Four changes included in new case definition, including no required duration of subjective or measured fever
Addition of Immunomodulators Cuts Vascular Inflammation in RA
Significant reduction in disease activity seen for patients receiving TNFi or triple therapy, with no difference between them
Biomarkers May ID RA Patients With, Without Active Disease
Active disease in rheumatoid arthritis patients associated with higher values for inflammatory indices, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio
AI Can Identify Multisystem Inflammatory Syndrome in Children
Algorithm uses age, five signs of Kawasaki disease, and 17 laboratory measures
MI Outcomes May Be Worse in Patients With Rheumatic IMID
MI outcomes poorer in Medicare beneficiaries with versus without rheumatic immune-mediated inflammatory disease
Blood Biomarker Linked to Incident VTE in COVID-19 Patients
Higher levels of soluble urokinase plasminogen activator receptor linked to incident venous thromboembolism independently of D-dimer
Immune-Inflammatory Biomarkers Higher in Severe Mental Illness, T2DM
Increased peripheral levels of inflammatory biomarkers and oxidative stress biomarkers seen in people with severe mental illness or T2DM
Cases of Kawasaki Disease in the U.S. Dropped During Pandemic
Kawasaki disease cases fell by 28 percent and remained low during periods of pandemic-related masking and school closures
DDW: Antibiotics Up Risk of Older-Onset Inflammatory Bowel Disease
Findings regardless of antibiotic class and with a dose-response relationship
